FLT3/ITD mutations are normal in AML and, from APL apart, they often have a pronounced detrimental effect on clinical outcomes in any way stages of the condition
FLT3/ITD mutations are normal in AML and, from APL apart, they often have a pronounced detrimental effect on clinical outcomes in any way stages of the condition. patient account.1 Mutations in the FMS-like tyrosine kinase 3 (FLT3) gene signify one of the most frequently came across, and challenging clinically, course of AML mutations.2 Although approximately…